BridgeBio Pharma Inc Sustainability Reports
BridgeBio Pharma, Inc. is a commercial-stage biotechnology company focused on discovering, developing, and delivering transformative medicines for genetic diseases and cancers.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930028YG89VTY2J114
FIGI: BBG00P9KDZL5
9 reports from 2019 to 2025
